Seeing Is Believing
Currently out of the existing stock ratings of Nathan Rich, 26 are a SELL (23.42%), 46 are a BUY (41.44%), 39 are a HOLD (35.14%).
Analyst Nathan Rich works at GOLDMAN SACHS with a stock forecast success ratio of 66.01% fulfilled within 95.91 days on average.
Nathan Rich’s has documented 220 price targets and ratings displayed on 22 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVST, Envista Holdings Corp at 03-May-2024.
Analyst best performing recommendations are on OSCR (OSCAR HEALTH).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 4/7/2020. The price target of $40 was fulfilled within 2 days with a profit of $3.53 (9.68%) receiving and performance score of 48.4.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
22
$1.01 (4.81%)
1 years 10 months 21 days ago
3/4 (75%)
$1.33 (6.43%)
299
Buy
21
$0.01 (0.05%)
26
1 years 11 months 8 days ago
0/4 (0%)
$0.3 (1.45%)
Hold
1 years 11 months 11 days ago
1/3 (33.33%)
$7.54 (38.75%)
337
Buy
21
$0.01 (0.05%)
1 years 11 months 11 days ago
1/2 (50%)
$1.3 (6.60%)
54
Hold
22
1 years 11 months 11 days ago
0/2 (0%)
$6.55 (42.39%)
Which stock is Nathan Rich is most bullish on?
Which stock is Nathan Rich is most reserved on?
What Year was the first public recommendation made by Nathan Rich?